Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 033125/0055 | |
| Pages: | 5 |
| | Recorded: | 06/05/2014 | | |
Attorney Dkt #: | P-229 |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
2
|
|
Patent #:
|
|
Issue Dt:
|
03/08/2011
|
Application #:
|
12229748
|
Filing Dt:
|
08/26/2008
|
Publication #:
|
|
Pub Dt:
|
03/05/2009
| | | | |
Title:
|
AMIDOALKYL-8-AZABICYCLO[3.2.1]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS
|
|
|
Patent #:
|
|
Issue Dt:
|
08/27/2013
|
Application #:
|
13017412
|
Filing Dt:
|
01/31/2011
|
Publication #:
|
|
Pub Dt:
|
05/26/2011
| | | | |
Title:
|
AMIDOALKYL-8-AZABICYCLO[3.2.1]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS
|
|
Assignee
|
|
|
901 GATEWAY BOULEVARD |
SOUTH SAN FRANCISCO, CALIFORNIA 94080 |
|
Correspondence name and address
|
|
JEFFREY A. HAGENAH
|
|
PATENT DEPARTMENT
|
|
THERAVANCE BIOPHARMA US, INC.
|
|
901 GATEWAY BOULEVARD
|
|
SOUTH SAN FRANCISCO, CALIFORNIA 94080
|
Search Results as of:
06/21/2025 11:42 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|